Literature DB >> 34612811

Bayesian inference of population prevalence.

Robin Aa Ince1, Angus T Paton1, Jim W Kay2, Philippe G Schyns1.   

Abstract

Within neuroscience, psychology, and neuroimaging, the most frequently used statistical approach is null hypothesis significance testing (NHST) of the population mean. An alternative approach is to perform NHST within individual participants and then infer, from the proportion of participants showing an effect, the prevalence of that effect in the population. We propose a novel Bayesian method to estimate such population prevalence that offers several advantages over population mean NHST. This method provides a population-level inference that is currently missing from study designs with small participant numbers, such as in traditional psychophysics and in precision imaging. Bayesian prevalence delivers a quantitative population estimate with associated uncertainty instead of reducing an experiment to a binary inference. Bayesian prevalence is widely applicable to a broad range of studies in neuroscience, psychology, and neuroimaging. Its emphasis on detecting effects within individual participants can also help address replicability issues in these fields.
© 2021, Ince et al.

Entities:  

Keywords:  generalisation; human; inference; neuroscience; prevalence; statistics

Mesh:

Year:  2021        PMID: 34612811      PMCID: PMC8494477          DOI: 10.7554/eLife.62461

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.713


  42 in total

1.  How many subjects constitute a study?

Authors:  K J Friston; A P Holmes; K J Worsley
Journal:  Neuroimage       Date:  1999-07       Impact factor: 6.556

2.  Diverse and temporally precise kinetic feature selectivity in the VPm thalamic nucleus.

Authors:  Rasmus S Petersen; Marco Brambilla; Michael R Bale; Andrea Alenda; Stefano Panzeri; Marcelo A Montemurro; Miguel Maravall
Journal:  Neuron       Date:  2008-12-10       Impact factor: 17.173

3.  Scientists rise up against statistical significance.

Authors:  Valentin Amrhein; Sander Greenland; Blake McShane
Journal:  Nature       Date:  2019-03       Impact factor: 49.962

4.  Beyond differences in means: robust graphical methods to compare two groups in neuroscience.

Authors:  Guillaume A Rousselet; Cyril R Pernet; Rand R Wilcox
Journal:  Eur J Neurosci       Date:  2017-06-29       Impact factor: 3.386

5.  The reliability paradox: Why robust cognitive tasks do not produce reliable individual differences.

Authors:  Craig Hedge; Georgina Powell; Petroc Sumner
Journal:  Behav Res Methods       Date:  2018-06

6.  Natural scene statistics account for the representation of scene categories in human visual cortex.

Authors:  Dustin E Stansbury; Thomas Naselaris; Jack L Gallant
Journal:  Neuron       Date:  2013-08-08       Impact factor: 17.173

7.  Dynamic Construction of Reduced Representations in the Brain for Perceptual Decision Behavior.

Authors:  Jiayu Zhan; Robin A A Ince; Nicola van Rijsbergen; Philippe G Schyns
Journal:  Curr Biol       Date:  2019-01-10       Impact factor: 10.834

8.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

9.  Parallel Interdigitated Distributed Networks within the Individual Estimated by Intrinsic Functional Connectivity.

Authors:  Rodrigo M Braga; Randy L Buckner
Journal:  Neuron       Date:  2017-07-19       Impact factor: 17.173

View more
  2 in total

1.  Different computations over the same inputs produce selective behavior in algorithmic brain networks.

Authors:  Katarzyna Jaworska; Yuening Yan; Nicola J van Rijsbergen; Robin A A Ince; Philippe G Schyns
Journal:  Elife       Date:  2022-02-17       Impact factor: 8.140

2.  Neurocomputational mechanisms underlying cross-modal associations and their influence on perceptual decisions.

Authors:  Joshua Bolam; Stephanie C Boyle; Robin A A Ince; Ioannis Delis
Journal:  Neuroimage       Date:  2021-12-21       Impact factor: 7.400

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.